Draft amendments to the Rules for marketing authorization and assessment of medicinal products for human use; (24 page(s), in Russian)

Draft Resolution number 1092, 03 May 2022; (9 page(s), in Portuguese)

Draft resolution number 1108, 18 August 2022;; (20 page(s), in Portuguese)